These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7340986)

  • 21. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
    Fontelonga A; Kelly AJ; MacKintosh FR; Hall S; Monroe P; Wilson GS; Shaft D; Ruthven A; Ascensao JL
    Bone Marrow Transplant; 1997 May; 19(10):983-8. PubMed ID: 9169642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
    Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Has current adjuvant cytostatic therapy in radically operated breast cancer patients failed?].
    Sauter C
    Schweiz Med Wochenschr; 1983 Mar; 113(12):414-7. PubMed ID: 6857192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.
    Ludwig Breast Cancer Study Group
    N Engl J Med; 1988 Sep; 319(11):677-83. PubMed ID: 2901037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mastectomy as an adjunct to combination chemotherapy.
    Morris D; Aisner J; Elias EG; Wiernik PH
    Arch Surg; 1978 Mar; 113(3):282-4. PubMed ID: 205189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
    Sulkes A; Brufman G; Rizel S; Weshler Z; Biran S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1983 Jan; 9(1):17-21. PubMed ID: 6687724
    [No Abstract]   [Full Text] [Related]  

  • 31. The prognostic importance of myelosuppression in the response to chemotherapy and survival in advanced ovarian carcinoma.
    Sorbe B; Helsing M
    Cancer; 1987 Feb; 59(4):690-4. PubMed ID: 3802028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer.
    Schyrr F; Wolfer A; Pasquier J; Nicoulaz AL; Lamy O; Naveiras O
    Ann Hematol; 2018 Feb; 97(2):309-317. PubMed ID: 29170810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
    Cameron DA; Craig J; Gabra H; Lee L; MacKay J; Parker AC; Leonard RC; Anderson E; Anderson T; Chetty U; Dixon M; Hawkins A; Jack W; Kunkler I; Leonard R; Matheson L; Miller W
    Br J Cancer; 1996 Dec; 74(12):2013-7. PubMed ID: 8980406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.
    Rose DP; Davis TE
    Lancet; 1977 Jun; 1(8023):1174-6. PubMed ID: 68275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of breast cancer: current views and results.
    Bonadonna G; Valagussa P
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):279-97. PubMed ID: 6341335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose intensity of standard adjuvant CMF with granulocyte colony-stimulating factor for premenopausal patients with node-positive breast cancer.
    de Graaf H; Willemse PH; Bong SB; Piersma H; Tjabbes T; van Veelen H; Coenen JL; de Vries EG
    Oncology; 1996; 53(4):289-94. PubMed ID: 8692532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
    [No Abstract]   [Full Text] [Related]  

  • 40. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer.
    Rubens RD; Hayward JL; Knight RK; Bulbrook RD; Fentiman IS; Chaudary M; Howell A; Bush H; Crowther D; Sellwood RA; George WD; Howat JM
    Lancet; 1983 Apr; 1(8329):839-43. PubMed ID: 6132179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.